Data / Form D filings / Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.: Form D filings
Crinetics Pharmaceuticals, Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC between 2015 and 2024. The latest, on March 11, 2024, reports $350 million sold of a $350 million offering to 36 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6055 LUSK BOULEVARD, San Diego, CA, 92121
- Phone
- (858) 450-6464
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1658247
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | New notice | $350,000,028 | $350,000,028 | 36 | Mar 1, 2024 | sec.gov | |
| Feb 23, 2018 | New notice | $65,000,001 | $59,999,999 | $5,000,002 | 12 | Feb 9, 2018 | sec.gov |
| Nov 16, 2015 | New notice | $40,000,004 | $18,000,001 | $22,000,003 | 8 | Oct 30, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JAMES VIVALDI HASSARD | Executive Officer | |
| STEPHEN VIVALDI BETZ | Executive Officer | |
| ROGERIO VIVALDI COELHO, M.D. | Director | |
| WESTON SCOTT NICHOLS, PhD | Director | |
| MARC SCOTT WILSON | Executive Officer | |
| CAMILLE SCOTT BEDROSIAN, M.D. | Director | |
| MATTHEW SCOTT FUST | Director | |
| RICHARD SCOTT STRUTHERS, PhD | Executive Officer, Director | |
| JEFF VIVALDI KNIGHT | Executive Officer | |
| WENDELL SCOTT WIERENGA, PhD | Director | |
| DANA VIVALDI PIZZUTI | Executive Officer | |
| CAREN SCOTT DEARDORF | Director | |
| STEPHANIE SCOTT OKEY | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 11, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Crinetics Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.